Bill Gates Announces $100M In Personal Funding For Dementia, Alzheimer’s Research

Financial Times: Gates joins Alzheimer’s fight with $50m dementia fund investment
“Bill Gates has made his first move to support Alzheimer’s disease research, with a $50m investment in the London-based Dementia Discovery Fund. The DDF provides venture finance for companies developing innovative treatments for Alzheimer’s and related neurodegenerative diseases…” (Cookson, 11/13).

Reuters: Bill Gates makes $100 million personal investment to fight Alzheimer’s
“…The investment — a personal one and not part of Gates’ philanthropic Bill & Melinda Gates Foundation — will be followed by another $50 million in start-up ventures working in Alzheimer’s research, Gates said. With rapidly rising numbers of people suffering from Alzheimer’s and other forms of dementia, the disease is taking a growing emotional and financial toll as people live longer, Gates told Reuters in an interview…” (Kelland, 11/13).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.